Cloud DX (TSX-V:CDX, OTCQB:CDXFF) Inc announced the launch of its first remote patient monitoring (RPM) program for type 2 diabetes patients at an Ontario healthcare organization that is a current Cloud DX (TSX-V:CDX, OTCQB:CDXFF) client.
In a statement, the company said the new program will use existing remote care monitoring (RCM) tools to augment/replace manual data collection activities within the existing patient population.
Upon reaching their goal of enrolling 100 patients, the account would generate up to C$48,000 per year in recurring revenue, Cloud DX said.
READ: Cloud DX inks eighth contract with Ontario paramedicine program to bring remote patient monitoring to community seniors
Connected Health allows for unlimited periodic monitoring of blood sugar levels and provides access to data that can help patients better understand and control their disease, the company explained.
Automated notifications inform individuals and their healthcare providers when blood sugar levels fall outside a specific range, helping them quickly identify and address potential problems. Targeted, customized surveys will allow for easy assessment of patients' symptoms, behaviour patterns and well-being, the company said.
Cloud DX also pointed out that the program will support both full Connected Health kits and a “bring your own device” option, which generally offers higher margins.
"Cloud DX's Connected Health RPM program for type 2 diabetes patients is a significant step forward in providing patients with the tools they need to manage their disease effectively,” Cloud DX COO Anthony Kaul commented.
“Connected Health will help individuals with type 2 diabetes better understand and control their disease, leading to better blood sugar control, fewer complications, and a better quality of life."
Cloud DX’s stated mission is to make healthcare better for everyone. The company’s Connected Health data platform is used by clinics and hospitals across North America to incorporate remote and virtual technology in care delivery.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie